Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. Co. operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. Co. is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. We show 57 historical shares outstanding datapoints in our ENZ shares outstanding history coverage, used to compute ENZ market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ENZ market cap history over the course of time is important for investors
interested in comparing ENZ's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ENZ versus a peer is one thing; comparing
ENZ market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ENZ can fluctuate over the course of history.
With this page we aim to empower investors researching ENZ by allowing them to research the ENZ market cap history. |
Free ENZ Email Alerts:
Video: The Importance of Market Cap
